LENZ Therapeutics, Inc. SEC filings LENZ
LENZ Therapeutics, Inc. has 359 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, exit or restructuring costs, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 4, 2026 | — |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 2, 2026 | — |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 8, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 26, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 15, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 8, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 7, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 7, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 22, 2025 | — |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 20, 2025 | — |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 14, 2025 | — |
| 4 | Insider transaction | Jul 14, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 12, 2025 | — |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 9, 2025 | — |
| 4 | Insider transaction | Apr 9, 2025 | Apr 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 27, 2025 | — |
| 4 | Insider transaction | Mar 7, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jul 29, 2024 | — |
| 4 | Insider transaction | Jul 23, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | May 15, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 8, 2024 | — |
| 3 | Initial insider ownership | Mar 28, 2024 | Mar 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 28, 2024 | — |
| SC 13D | Ownership over 5% (active) | Mar 28, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 25, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 25, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 25, 2024 | — |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Mar 25, 2024 | Mar 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 5, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 17, 2023 | — |
| 4 | Insider transaction | Aug 1, 2023 | Jul 28, 2023 |
| 3 | Initial insider ownership | Aug 1, 2023 | Jul 28, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Feb 23, 2023 | Feb 21, 2023 |
| 4 | Insider transaction | Feb 23, 2023 | Feb 21, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 9, 2023 | — |
| 3 | Initial insider ownership | Jan 6, 2023 | Jan 6, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 12, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Nov 18, 2022 | — |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 21, 2022 |
| 4 | Insider transaction | Apr 13, 2022 | Apr 11, 2022 |
| 4 | Insider transaction | Apr 13, 2022 | Apr 11, 2022 |
| 4 | Insider transaction | Apr 5, 2022 | Apr 1, 2022 |
| 3 | Initial insider ownership | Apr 5, 2022 | Apr 1, 2022 |
| 4 | Insider transaction | Feb 18, 2022 | Feb 16, 2022 |
| 4 | Insider transaction | Feb 18, 2022 | Feb 16, 2022 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2022 | — |
| 4 | Insider transaction | Jan 25, 2022 | Jan 21, 2022 |
| 4 | Insider transaction | Jan 21, 2022 | Jan 19, 2022 |
| 4 | Insider transaction | Dec 20, 2021 | Dec 15, 2021 |
| 4 | Insider transaction | Nov 24, 2021 | Nov 22, 2021 |
| 4 | Insider transaction | Oct 15, 2021 | Oct 13, 2021 |
| SC 13G | Ownership over 5% (passive) | Oct 12, 2021 | — |
| 4 | Insider transaction | Oct 8, 2021 | Oct 6, 2021 |
| SC 13D | Ownership over 5% (active) | Jul 9, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Jul 9, 2021 | — |
| 4 | Insider transaction | Jul 1, 2021 | Jun 29, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jan 13, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 29, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Apr 15, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jan 13, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jan 13, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jan 13, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jan 13, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 29, 2021 |
| 4 | Insider transaction | Jun 28, 2021 | Jun 24, 2021 |
| 4 | Insider transaction | Jun 28, 2021 | Feb 16, 2021 |
| 4 | Insider transaction | Jun 28, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
Showing 177 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- LENZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1815776
- Former names
- Graphite Bio, Inc. (until Mar 19, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.